The rapid growth of private equity in health care has attracted widespread attention & concern
Our new @JAMA_current study finds that when private equity takes over a hospital, patients' care experience significantly worsens.
https://t.co/FEjtttopA0
Search engines gave patients documents. LLMs give them an interpretation and a plan.
The information asymmetry that reinforced the physician's authority is eroding. Where that leaves physicians, in my Editor's Page (free to read): https://t.co/jp4vWtqvT0
@JACCJournals
Excited for the launch of the Smith Institute for Evidence, Innovation, and Policy—tackling health care’s biggest questions and turning evidence into better care and healthier lives
Honored to serve as Director of the Institute & lead this next chapter with @rwyeh@BIDMChealth
Read more: https://t.co/2gJTv9C8AZ
Big news: BIDMC's Smith Center for Outcomes Research is now the Richard A. and Susan F. Smith Institute for Evidence, Innovation, and Policy. A new chapter focused on evidence, innovation, AI, workforce development, and advancing better health care.
🔗 https://t.co/vcR3k0OBPx
I'm excited to announce our transition to become the Richard A. and Susan F. Smith Institute for Evidence, Innovation and Policy.
Read more about the Smith Institute's evolution here:
https://t.co/W4JvFSiNnj
Excited for the launch of the Smith Institute for Evidence, Innovation, and Policy—tackling health care’s biggest questions and turning evidence into better care and healthier lives
Honored to serve as Director of the Institute & lead this next chapter with @rwyeh@BIDMChealth
Read more: https://t.co/2gJTv9C8AZ
After a decade of growth, we’re now the Richard A. and Susan F. Smith Institute for Evidence, Innovation, and Policy.
The Institute's centers will bring together bold ideas, rigorous science, and clinical expertise to improve people’s health and lives.
https://t.co/3YA6aTFxI0
Heart failure is a significant global public health burden, and the impact is likely to increase
Global, Regional, and National Burden of Heart Failure, 1990-2023
https://t.co/nC7y6fjyNZ
@JAMACardio@JAMA_current
Does Medicare coverage type influence outcomes after #TAVR?
Using Medicare claims, paper compares MA vs FFS:
🔹 TAVR utilization
🔹 Patient & hospital characteristics
🔹30–150-day & 1-year outcomes
Read More⬇️
@AHAScience@ChristinaLalani@rwyeh@rkwadhera@djc795 @JMKimMD
Research by @harvardmed student Christy Zheng found that approximately 52% of older adults treated with anthracyclines received no echo within 18 months, with wide variation across hospitals & providers. @JACCJournals@DocStrom@JenicaUpshaw
🔗 https://t.co/9JROOcXTIB
🎬 Ashley Kyalwazi discusses her experience as a Zimetbaum Fellow and how it influenced her research and career goals.
Interested in conducting your own high-impact outcomes research? Apply for the Zimetbaum Fellowship by October 16th: https://t.co/sc3sbjwQBo
The new NCDR Renal Denervation Module from @ACCinTouch, developed with the Smith Center, is open for enrollment!
Learn more about this collaboration and join more than a dozen sites already enrolled in the RDN Module: https://t.co/vWOFX6mWsO
@EricSecemskyMD@AKrawisz
Tomorrow, we’re ready to go.
Colleagues will join us in Boston—and tune in worldwide—for the inaugural Boston Sports Cardiology Summit.
Join @katiemstewart7 and me Sept 25–26, in person or live online. Registration remains open:
https://t.co/xo5k3Q2mSM
🎬 Chantal Henry, 2022-23 Zimetbaum Fellow, speaks about her experience conducting high-impact outcomes research at the Smith Center.
Interested in the Zimetbaum Fellowship? Learn more and apply by October 16th: https://t.co/sc3sbjwiLQ
Excited to share that our lab has been awarded an R01 from the @NIH to investigate the molecular determinants of dynamic BP response to stressors. Incredibly grateful for the mentorship and support I have received @BidmcCvi , as well as for our collaborators across #TOPMed (1/2)
Very proud of Stephen Mein on being awarded an NHLBI K23 grant
Inhalers are a case study in how US drug pricing and coverage fail patients with chronic disease — and he's building the evidence on what actually fixes it
Watch out for his work! @SmithBIDMC@PCCSM_BIDMC
Cardiogenic shock patients suffer high mortality, and outcome improvement has lagged. @ChristinaLalani & @rwyeh discuss ways to generate better evidence to inform the identification of effective treatments in their @CircHF editorial: https://t.co/wskxPz1WHl
Congratulations to @StephenMein on receiving an NIH K23 Career Development Award!
His work will examine how recent prescription drug pricing policies are shaping inhaler access, adherence, and clinical outcomes for adults living with asthma and COPD.
Are you a US med student or resident interested in health outcomes research, health policy, population sciences, and/or medical technology evaluation? The Zimetbaum Fellowship may be for you! Learn more and apply by Oct. 16th: https://t.co/8oplngCEBH
Very proud of Stephen Mein on being awarded an NHLBI K23 grant
Inhalers are a case study in how US drug pricing and coverage fail patients with chronic disease — and he's building the evidence on what actually fixes it
Watch out for his work! @SmithBIDMC@PCCSM_BIDMC